10/02/2006 - 10:27

pSivida's Retisert to be co-promoted in the US

10/02/2006 - 10:27

Bookmark

Save articles for future reference.

Shares in Western Australia's biggest biotechnology stock, pSivida Ltd, have risen 7 per cent following news that its Retisert product, licensed to Bausch & Lomb, will be co-promoted in the United States by Novartis Ophthalmics.

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options